Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07138560 · ClinicalTrials.gov registry record · Phase 4

BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease

A Phase 4 study of Parkinson Disease, sponsored by The Cleveland Clinic.

Recruiting
Registry status
Phase 4
Development phase
22
Enrollment target
1
Study location

NCT07138560 is a Phase 4 study of Parkinson Disease that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 22 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07138560, a Phase 4 study of Parkinson Disease, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
Phase 4
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effect of IPX203 (Crexont®) - the newest extended-release levodopa formulation - on the duration and quality of good on time, using a wearable device to monitor symptoms. 'Good on time' refers to a period (minutes to hours) when a patient experiences optimal symptom control due to effective medication and has better overall functioning without troublesome dyskinesias. The change in the duration and quality of on-time will be measured by a wearable device placed on your wrist called KinesiaU.

Conditions Studied

Parkinson Disease

Interventions

  • DRUG CREXONT ER

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2025-07-24
Est. Completion 2027-05-15
Phase Phase 4

Sponsor

The Cleveland Clinic

688 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07138560

The ClinicalTrials.gov registry entry for NCT07138560 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which CREXONT ER is the first listed.

NCT07138560 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT07138560 about?

NCT07138560 is a clinical study titled "BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease". The purpose of this study is to evaluate the effect of IPX203 (Crexont®) - the newest extended-release levodopa formulation - on the duration and quality of good on time, using a wearable device to monitor symptoms. 'Good on time' refers to a period (minutes to hours) when a patient experiences opti...

What is the current status of trial NCT07138560?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2025-07-24. Estimated completion is 2027-05-15.

What conditions does trial NCT07138560 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT07138560?

The interventions under investigation include: CREXONT ER (DRUG).

Who is sponsoring clinical trial NCT07138560?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07138560 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.